74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
A Ambu A-S
A
Closed
68.15 0.74
Overview
Share price change
24h
Min
64.45
Max
68.9
Income | 3M 118M |
|---|---|
Sales | 92M 1.6B |
P/E Sector Avg | 35.196 57.833 |
EPS | 0.44 |
Dividend yield | 0.57 |
Profit margin | 7.574 |
Employees | 5,200 |
EBITDA | 31M 265M |
Dividend yield Sector Avg | 0.57% 2.47% |
|---|---|
Next Earnings | 6 May 2026 |
Market Cap | -3.4B 19B |
|---|---|
Previous open | 67.41 |
Previous close | 68.15 |
Ambu A-S Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Ambu A-S Forecast
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Ambu A-S
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products; airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, resuscitators, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
Live chat